Seres Therapeutics (MCRB) Investor Presentation - Slideshow
Seres Therapeutics(MCRB)2023-03-21 23:11
Seres Therapeutics Corporate Overview March 2023 2 Forward Looking Statements Some of the statements in this presentation constitute "forward looking statements" under the Private Securities Litigation Reform Act of 1995, including, but not limited to the potential approval and launch of SER-109; the anticipated indication for SER-109; the anticipated supply of SER-109; the potential for microbiome therapeutics to protect against infection; the timing of clinical development; our development opportunities a ...